Detection of ovarian cancer by ¹⁹⁸au‐labeled human monoclonal antibody

Medicine and Dentistry

• Adenocarcinoma 9%
• Affinity Chromatography 9%
• Amaurosis 9%
• Antibody 100%
• Antibody Combining Site 9%
• Antibody Specificity 9%
• Biopsy 36%
• Cancer Cell 9%
• Early Diagnosis 18%
• Gold 198 9%
• Human Monoclonal Antibody 18%
• Immunoreactivity 27%
• In Vitro 9%
• Malignant Neoplasm 9%
• Membrane Antigen 9%
• Monoclonal Antibody 18%
• Ovarian Cancer 54%
• Ovary 9%
• Patient 9%
• Sensitivity and Specificity 9%
• Sepharose 9%
• Specimen 54%